Skip to main content
# Title Department Research Year
2391 Synthesis and Potential Biological Activities of Certain New
Substituted Thiazoline-Quinoline Derivatives
Department of Pharmaceutical Organic Chemistry 2009
2392 Evaluation of The Pharmacokinetic of New Amantadine Prodrugs As Hepatic Delivery Systems to Enhance Its Activity Against HCV by A New HPLC Method. Department of Pharmaceutical Analytical Chemistry 2009
2393 Improvement of solubility and dissolution rate of indomethacin by solid dispersion in Gelucire 50/13 and PEG 4000. Department of Pharmaceutics 2009
2394 Solution-Phase Synthesis of Small Schiff Bases Combinatorial Library with Potential Antitubercular Activity Department of Medicinal Chemistry 2009
2395 CYTOTOXIC ACTIVITY OF CROTALARIA THEBAICA (DEL) DC. AND MAERUA CRASSIFOLIA GROWING IN EGYPT
Department of Pharmacognosy 2009
2396 New Isoflavone Glycosides from Iris spuria L. (Calizona)
Cultivated in Egypt
Department of Pharmacognosy 2009
2397 BACE1 Inhibitors: Optimization by Replacing the P1’
Residue with Non-Acidic Moiety
Department of Medicinal Chemistry 2008
2398 A Sensitive Spectrophotometric Method for the
Determination of H2-Receptor Antagonists by Means of NBromosuccinimide
and p-Aminophenol
Department of Pharmaceutical Analytical Chemistry 2008
2399 Comparative Evaluation of Liquid Chromatography–Mass
Spectrometry Versus Gas Chromatography–Mass
Spectrometry for the Determination of Hexabromocyclododecanes
and Their Degradation Products in Indoor Dust
Department of Pharmaceutical Analytical Chemistry 2008
2400 Design, synthesis, and structure-affinity relationships of novel series of sialosides as CD22-specific inhibitors Department of Pharmaceutical Organic Chemistry 2008